Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls

Faith Dickerson, Cassie Stallings, Andrea Origoni, Emily Katsafanas, Lucy Schweinfurth, Christina Savage, Sunil Khushalani, Robert H Yolken

Research output: Contribution to journalArticle

Abstract

Increased rates of exposure to Toxoplasma gondii have been found in individuals with schizophrenia and bipolar disorder, but the association between Toxoplasma and cognitive functioning has not previously been examined. We measured IgG and IgM class antibodies to Toxoplasma in 408 nonelderly individuals with schizophrenia, 347 with bipolar disorder, and 352 nonpsychiatric controls. Cognitive functioning was measured with the Repeatable Battery for the Assessment of Neuropsychological Status. Multivariate linear and regression analyses showed significant associations between Toxoplasma IgM antibody level and cognitive scores within the control group and the bipolar disorder group but not the schizophrenia group. Within the control group, having an elevated Toxoplasma IgM antibody level, greater than or equal to the 50th and 75th levels of the control group, was associated with significantly elevated odds of a low total cognitive score. Exposure to Toxoplasma may confer risk for lower cognitive functioning in persons without a psychiatric disorder and those with bipolar disorder.

Original languageEnglish (US)
Pages (from-to)589-593
Number of pages5
JournalJournal of Nervous and Mental Disease
Volume202
Issue number8
DOIs
StatePublished - 2014

Fingerprint

Toxoplasma
Bipolar Disorder
Schizophrenia
Antibodies
Immunoglobulin M
Control Groups
Immunoglobulin Isotypes
Psychiatry
Linear Models
Multivariate Analysis
Immunoglobulin G
Regression Analysis

Keywords

  • bipolar disorder
  • cognition
  • infection
  • parasite
  • Schizophrenia
  • Toxoplasma gondii

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls. / Dickerson, Faith; Stallings, Cassie; Origoni, Andrea; Katsafanas, Emily; Schweinfurth, Lucy; Savage, Christina; Khushalani, Sunil; Yolken, Robert H.

In: Journal of Nervous and Mental Disease, Vol. 202, No. 8, 2014, p. 589-593.

Research output: Contribution to journalArticle

Dickerson, Faith ; Stallings, Cassie ; Origoni, Andrea ; Katsafanas, Emily ; Schweinfurth, Lucy ; Savage, Christina ; Khushalani, Sunil ; Yolken, Robert H. / Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls. In: Journal of Nervous and Mental Disease. 2014 ; Vol. 202, No. 8. pp. 589-593.
@article{604ff61321854977abb58c06b024d837,
title = "Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls",
abstract = "Increased rates of exposure to Toxoplasma gondii have been found in individuals with schizophrenia and bipolar disorder, but the association between Toxoplasma and cognitive functioning has not previously been examined. We measured IgG and IgM class antibodies to Toxoplasma in 408 nonelderly individuals with schizophrenia, 347 with bipolar disorder, and 352 nonpsychiatric controls. Cognitive functioning was measured with the Repeatable Battery for the Assessment of Neuropsychological Status. Multivariate linear and regression analyses showed significant associations between Toxoplasma IgM antibody level and cognitive scores within the control group and the bipolar disorder group but not the schizophrenia group. Within the control group, having an elevated Toxoplasma IgM antibody level, greater than or equal to the 50th and 75th levels of the control group, was associated with significantly elevated odds of a low total cognitive score. Exposure to Toxoplasma may confer risk for lower cognitive functioning in persons without a psychiatric disorder and those with bipolar disorder.",
keywords = "bipolar disorder, cognition, infection, parasite, Schizophrenia, Toxoplasma gondii",
author = "Faith Dickerson and Cassie Stallings and Andrea Origoni and Emily Katsafanas and Lucy Schweinfurth and Christina Savage and Sunil Khushalani and Yolken, {Robert H}",
year = "2014",
doi = "10.1097/NMD.0000000000000166",
language = "English (US)",
volume = "202",
pages = "589--593",
journal = "Journal of Nervous and Mental Disease",
issn = "0022-3018",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls

AU - Dickerson, Faith

AU - Stallings, Cassie

AU - Origoni, Andrea

AU - Katsafanas, Emily

AU - Schweinfurth, Lucy

AU - Savage, Christina

AU - Khushalani, Sunil

AU - Yolken, Robert H

PY - 2014

Y1 - 2014

N2 - Increased rates of exposure to Toxoplasma gondii have been found in individuals with schizophrenia and bipolar disorder, but the association between Toxoplasma and cognitive functioning has not previously been examined. We measured IgG and IgM class antibodies to Toxoplasma in 408 nonelderly individuals with schizophrenia, 347 with bipolar disorder, and 352 nonpsychiatric controls. Cognitive functioning was measured with the Repeatable Battery for the Assessment of Neuropsychological Status. Multivariate linear and regression analyses showed significant associations between Toxoplasma IgM antibody level and cognitive scores within the control group and the bipolar disorder group but not the schizophrenia group. Within the control group, having an elevated Toxoplasma IgM antibody level, greater than or equal to the 50th and 75th levels of the control group, was associated with significantly elevated odds of a low total cognitive score. Exposure to Toxoplasma may confer risk for lower cognitive functioning in persons without a psychiatric disorder and those with bipolar disorder.

AB - Increased rates of exposure to Toxoplasma gondii have been found in individuals with schizophrenia and bipolar disorder, but the association between Toxoplasma and cognitive functioning has not previously been examined. We measured IgG and IgM class antibodies to Toxoplasma in 408 nonelderly individuals with schizophrenia, 347 with bipolar disorder, and 352 nonpsychiatric controls. Cognitive functioning was measured with the Repeatable Battery for the Assessment of Neuropsychological Status. Multivariate linear and regression analyses showed significant associations between Toxoplasma IgM antibody level and cognitive scores within the control group and the bipolar disorder group but not the schizophrenia group. Within the control group, having an elevated Toxoplasma IgM antibody level, greater than or equal to the 50th and 75th levels of the control group, was associated with significantly elevated odds of a low total cognitive score. Exposure to Toxoplasma may confer risk for lower cognitive functioning in persons without a psychiatric disorder and those with bipolar disorder.

KW - bipolar disorder

KW - cognition

KW - infection

KW - parasite

KW - Schizophrenia

KW - Toxoplasma gondii

UR - http://www.scopus.com/inward/record.url?scp=84905391531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905391531&partnerID=8YFLogxK

U2 - 10.1097/NMD.0000000000000166

DO - 10.1097/NMD.0000000000000166

M3 - Article

C2 - 25010110

AN - SCOPUS:84905391531

VL - 202

SP - 589

EP - 593

JO - Journal of Nervous and Mental Disease

JF - Journal of Nervous and Mental Disease

SN - 0022-3018

IS - 8

ER -